The influence of the central region containing residues 19-25 on the aggregation properties and secondary structure of Alzheimer's β-amyloid peptide

European Journal of Biochemistry

Volumn 256, Issue 3, 1998, Pages 560-569

  El Agnaf, Omar M A ^a   Guthrie, David J S ^a   Walsh, Dominic M ^a   Irvine, G Brent ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

A aggregation; Alzheimer's disease; Amyloid; Secondary structure

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROCESSING; PROTEIN SECONDARY STRUCTURE; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; FREEZE DRYING; HUMANS; MICROSCOPY, ELECTRON; PEPTIDE MAPPING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; SOLUBILITY;

EID: 0032530466     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1998.2560560.x     Document Type: Article

References (50)

1. Kowall, N. W., Beal, M. F., Busciglio, J., Duffy, L. K. & Yankner, B. A. (1991) An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P, Proc. Natl Acad. Sci. USA 88, 7247-7251.
2. Yankner, B. A., Duffy, L. K. & Kirschner, D. A. (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides, Science 250, 279-282.
3. Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G. & Cotman, C. W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state, J. Neurosci. 13, 1676-1687.
4. Iversen, L. L., Mortishire-Smith, R. J., Pollack, S. J. & Shearman, M. S. (1995) The toxicity in vitro of β-amyloid protein, Biochem. J. 311, 1-16.
5. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagoplan, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masliah, E., McConlogue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B. & Zhao, J. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein, Nature 373, 523-527.
6. Pike, C. J., Walencewicz, A. J., Glabe, C. G. & Cotman, C. W. (1991) In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity, Brain Res. 563, 311-314.
7. Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I., Becker, G. W., Brems, D. N. & Li, W. Y. (1994) Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro, Mol. Pharmacol. 45, 373-379.
8. Barrow, C. J. & Zagorski, M. G. (1991) Solution structures of β peptide and its constituent fragments: relation to amyloid deposition, Science 253, 179-182.
9. Barrow, C. J., Yasuda, A., Kenny, P. T. M. & Zagorski, M. Q. (1992) Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. Analysis of circular dichroism spectra, J. Mol. Biol. 225, 1075-1093.
10. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C. & Glabe, C. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs, J. Biol. Chem. 267, 546-554.
11. Pike, C. J., Overman, M. J. & Cotman, C. W. (1995) Amino-terminal deletions enhance aggregation of β-amyloid peptide in vitro, J. Biol. Chem. 270, 23895-23898.
12. Dill, K. A. (1990) Dominant forces in protein folding, Biochemistry 29, 7133-7155.
13. Jarrett, J. T., Berger, E. P. & Lansbury, P. T. Jr (1993) The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease, Biochemistry 32, 4693-4697.
14. Pike, C. J., Walencewicz-Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G. & Cotman, C. W. (1995) Structure-activity analyses of β-amyloid peptides: contributions of the β25-region to aggregation and neurotoxicity, J. Neurochem. 64, 253-265.
15. 1H NMR of Aβ amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence, Biochemistry 34, 5191-5200.
16. Takadera, T., Sakura, N., Mohri, T. & Hashimoto, T. (1993) Toxic effect of a β-amyloid peptide β (22-35) on the hippocampal neuron and its prevention, Neurosci. Lett. 161, 41-44.
17. Kaneko, I., Yamada, N., Sakuraba, Y., Kamenosono, M. & Tutumi, S. (1995) Suppression of mitochondrial succinate dehydrogenase, a primary target of β-amyloid, and its derivative racemized at Ser residue, J. Neurochem. 65, 2585-2593.
18. Golabek, A. A., Soto, C., Vogel, T. & Wisniewski, T. (1996) The interaction between apolipoprotein E and Alzheimer's amyloid β-peptide is dependent on β-peptide conformation, J. Biol. Chem. 271, 10602-10606.
19. Tjernberg, L. O., Naslund, J., Lindqvist, F., Johansson, J., Karlstrom, A. R., Thyberg, J., Terenius, L. & Nordstedt, C. (1996) Arrest of β-amyloid fibril formation by a pentapeptide ligand, J. Biol. Chem. 271, 8545-8548.
20. Hendricks, I., Van Duijn, C. M., Cras, P., Cruts, M., Van Hul, W., Van Harskamp, F., Warren, A., McInnis, M. G., Antonarakis, S. E., Martin, J.-J., Hofman, A. & Van Broeckhoven, C. (1992) Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene, Nature Genet. 1, 218-221.
21. Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., Van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W. & Frangione, B. (1990) Mutation of the Akheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type, Science 248, 1124-1126.
22. Wisniewski, T. Ghiso, J. & Frangione, B. (1991) Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine tor glutamic acid substitution have accelerated amyloid fibril formation, Biochem. Biophys. Res. Commun. 179, 1247-1254.
23. Clements, A., Walsh, D. M., Williams, C. H. & Allsop, D. (1993) Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid β/A4 peptide, Neurosci. Lett. 161, 17-20.
24. Clements, A., Allsop, D., Walsh, D. M. & Williams, C. H. (1996) Aggregation and metal-binding properties of mutant forms of the amyloid Aβ peptide of Alzheimer's disease, J. Neurochem. 66, 740-747.
25. Soto, C. & Castano, E. M. (1996) The conformation of Alzheimer's β peptide determines the rate of amyloid formation and its resistance to proteolysis, Biochem. J. 314, 701-707.
26. Haass, C., Hung, A. Y., Selkoe, D. J. & Teplow, D. B. (1994) Mutations associated with a locus for Familial Alzheimer's Disease result in alternative processing of amyloid β-protein precursor, J. Biol. Chem. 269, 17741-17748.
27. Buchet, R., Tavitian, E., Ristig, D., Swoboda, R., Stauss, U., Gremlich, H. U., de La Fourniere, L., Staufenbiel, M., Frey, P. & Lowe, D. A. (1996) Conformations of synthetic β peptides in solid state and in aqueous solution: relation to toxicity in PC 12 cells, Biochim. Biophys. Acta 1315, 40-46.
28. Sherman, M. S. (1996) Cellular MTT reduction distinguishes the mechanism of action of β-amyloid from that of tachykinin receptor peptides, Neuropeptides 30, 125-132.
29. El-Agnaf, O. M. A., Harriott, P., Guthrie, D. J. S., Irvine, G. B. & Walker, B. (1994) The synthesis of some peptides related to the amyloid β peptide 25-35: use of N-(2-hydroxy-4-methoxybenzyl) protection, Lett. Pept. Sci. 1, 135-141.
30. Selkoe, D. J. (1994) Normal and abnormal biology of the β-amyloid precursor protein, Annu. Rev. Neurosci. 17, 489-517.
31. Terzi, E., Holzemann, G. & Seelig, J. (1994) Reversible random coil-β-sheet transition of the Alzheimer's β-amyloid fragment (25-35), Biochemistry 33, 1345-1350.
32. Terzi, K., Holzemann, G. & Seelig, J. (1994) Alzhemier β-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes, Biochemistry 33, 7434-7441.
33. Laczko, I., Holly, S., Konya, Z., Soos, K., Varga, J. L., Hollosi, M. & Penke, B. (1994) Conformational mapping of amyloid peptides from the putative neurotoxic 25-35 region, Biochem. Biophys. Res. Commun. 205, 120-126.
34. Sato, K., Wakamiya, A., Maeda, T., Noguchi, K., Takashima, A. & Imahori, K. (1995) Correlation among secondary structure, amyloid precursor protein accumulation, and neurotoxicity of amyloid β (25-35) peptide as analyzed by single alanine substitution, J. Biochem. 118, 1108-1111.
35. Sticht, H., Bayer, P., Willbold, D., Dames, S., Hilbich, C. Beyreuther, K., Frank, R. W. & Rosch, P. (1995) Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease, Eur. J. Biochem. 233, 293-298.
36. Soto, C., Castano, E. M., Frangione, B. & Inestrosa, N. C. (1995) The α-helical to β-strand transition in the amino-terminal fragment of the amyloid β-peptide modulates amyloid formation, J. Biol. Chem. 270, 3063-3067.
37. Snyder, S. W., Ladror, U. S., Wade, W. S., Wang, G. T., Barred, L. W., Matayoshi, E. D., Huffaker, H. J., Krafft, G. A. & Holzman, T. F. (1994) Amyloid-β aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths, Biophys. J. 67, 1216-1228.
38. Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. K. Floyd, R. A. & Butterfield, D. A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease, Proc. Natl Acad. Sci. USA 91, 3270-3274.
39. Maggio, J. E., Stimson, E. R., Ghilardi, J. R., Allen, C. J., Dahl, C. E., Whitcomb, D. C., Vigna, S. R., Vinters, H. V., Labenski, M. E. & Mantyh, P. W. (1992) Reversible in vitro growth of Alzheimer disease β-amyloid plaques by deposition of labeled amyloid peptide, Proc. Natl Acad. Sci. USA 89, 5462-5466.
40. El-Agnaf, O. M. A., Irvine, G. B. & Guthrie, D. J. S. (1997) Conformations of β-amyloid in solution, J. Neurochem. 68, 437-438.
41. Howlett, D. R., Jennings, K. H., Lee, D. C., Clark, M. S. G., Brown, F. Wetzel, R., Wood, S. J., Camilleri, P. & Roberts, G. W. (1995) Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide, Neurodegeneration 4, 23-32.
42. Soto, C., Castano, E. M., Kumar, R. A., Beavis, R. C. & Frangione, B. (1995) Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure, Neurosci. Lett. 200, 105-108.
43. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L. & Beyreuther, K. (1992) Substitutions of hydrophobic amino acid residues reduce the amyloidogenicity of Alzheimer's disease βA4 peptides, J. Mol. Biol. 228, 460-473.
44. Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M. & Teplow, D. B. (1997) Amyloid β-protein fibrillogenesis: detection of a protofibrillar intermediate, J. Biol. Chem. 272, 22364-22372.
45. Gowing, E., Roher, A. E., Woods, A. S., Cotter, R. J., Chaney, M., Little, S. P. & Ball, M. J. (1994) Chemical characterisation of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease, J. Biol. Chem. 269, 10987-10990.
46. Higgins, L. S., Murphy, G. M., Forno, L. S., Catalano, R. & Cordell, B. (1996) p3 β-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain, Am. J. Pathol. 149, 585-596.
47. Lalowski, M., Golabek, A., Lemere, C. A., Selkoe, D. J., Wisniewski, H. M., Beavis, R. C., Frangione, B. & Wisniewski, T. (1996) The 'nonamyloidogenic' p3 fragment (amyloid β17-42) is a major constituent of Down's syndrome cerebellar preamyloid, J. Biol. Chem. 271, 33623-33631.
48. Wood, S. J., Maleeff, B., Hart, T. & Wetzel, R. (1996) Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ, J. Mol. Biol. 256, 870-877.
49. Jarrett, J. T. & Lansbury, P. T. Jr (1992) Amyloid fibril formation requires a chemically discriminating nucleation event: Studies of an amyloidogenic sequence from the bacterial protein OsmB, Biochemistry 31, 12345-12352.
50. Esler, W. P., Stimson, E. R., Ghilardi, Lu, Y.-A., Felix, A. M., Vinters, H. V., J. R., Mantyh, P. W., Lee, J. P. & Maggio, J. E. (1996) Point substitution in the central hydrophobic cluster of a human β-amyloid congener disrupts peptide folding and abolishes plaque competence, Biochemistry 35, 13914-13921.